JAAD Publishes Reply on Tofacitinib and Skin Sclerosis Data
JAAD Volume 95, Issue 5 (November 2026) carries Yuan and colleagues' reply to Guo et al on the CRDC tofacitinib analysis in systemic sclerosis skin sclerosis.
Topic
Tofacitinib
Topic
Tofacitinib
JAAD Pilot Pits Mometasone Against Crisaborole and Tofacitinib
JAAD's November 2026 issue carries a randomized assessor-blinded pilot comparing mometasone 0.1%, crisaborole 2% and tofacitinib…